A phase I, single center, open label, randomized, single-dose, five-way crossover study to compare the pharmacokinetics of NP 101 (sumatriptan iontophoretic transdermal patch) with three formulations of Imitrex in healthy volunteers.

Trial Profile

A phase I, single center, open label, randomized, single-dose, five-way crossover study to compare the pharmacokinetics of NP 101 (sumatriptan iontophoretic transdermal patch) with three formulations of Imitrex in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2012

At a glance

  • Drugs Sumatriptan; Sumatriptan; Sumatriptan; Sumatriptan
  • Indications Migraine
  • Focus Pharmacokinetics
  • Sponsors NuPathe
  • Most Recent Events

    • 30 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top